Patent Assignment
Reel/Frame 061071/0600
Assignment of Assignor's Interest
Recorded: 2022-09-13
Pages: 5
Assignor
IMMUNOGEN, INC.
Executed: 2022-08-23
Assignee
IMMUNOGEN SWITZERLAND GMBH
HALDENSRASSE 5, BARR, 6340, SWITZERLAND
Covered Property
(1)
Combination Therapy for Treatment of Ovarian Cancer
Application:
63/369,460 →
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 4, 2022
From: PANDITE, ARUNDATHY; RANGWALA, FATIMA; LAMPKIN, TOM; SCHREIBER, TAYLOR
To: SHATTUCK LABS, INC.
Reel/Frame 060721/0389 →
Assignment of Assignor's Interest
Aug 4, 2022
From: METHOD, MICHAEL W.; WESTIN, ERIC H.
To: IMMUNOGEN, INC.
Reel/Frame 060721/0403 →
Patent Security Agreement
Apr 6, 2023
From: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 063282/0894 →
Release of Security Interest
Feb 12, 2024
From: BIOPHARMA CREDIT PLC
To: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
Reel/Frame 066553/0109 →